Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,000 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study.
Song R, Zeng G, Yu J, Meng X, Chen X, Li J, Xie X, Lian X, Zhang Z, Cao Y, Yin W, Jin R. Song R, et al. Among authors: meng x. Emerg Microbes Infect. 2023 Dec;12(1):2212806. doi: 10.1080/22221751.2023.2212806. Emerg Microbes Infect. 2023. PMID: 37157134 Free PMC article. Clinical Trial.
Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial.
Zhu D, Hu Y, Jiang Z, Yang T, Chu K, Zhang H, Hu J, Meng X, Tan Z, Wu J, Lian X, Li C, Pan H. Zhu D, et al. Among authors: meng x. Hum Vaccin Immunother. 2022 Nov 30;18(6):2135929. doi: 10.1080/21645515.2022.2135929. Epub 2022 Nov 28. Hum Vaccin Immunother. 2022. PMID: 36441137 Free PMC article. Clinical Trial.
Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.
Zhang Y, Qu JW, Zheng MN, Ding YX, Chen W, Ye SD, Li XY, Li YK, Liu Y, Zhu D, Jin CR, Wang L, Yang JY, Zhai Y, Wang EQ, Meng X. Zhang Y, et al. Among authors: meng x. Biomed Environ Sci. 2023 Jul 20;36(7):614-624. doi: 10.3967/bes2023.047. Biomed Environ Sci. 2023. PMID: 37533385 Free article.
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.
Le Corre N, Abarca K, Astudillo P, Potin M, López S, Goldsack M, Valenzuela V, Schilling A, Gaete V, Rubio L, Calvo M, Twele L, González M, Fuentes D, Gutiérrez V, Reyes F, Tapia LI, Villena R, Retamal-Díaz A, Cárdenas A, Alarcón-Bustamante E, Meng X, Xin Q, González-Aramundiz JV, Álvarez-Figueroa MJ, González PA, Bueno SM, Soto JA, On Behalf Of The PedCoronaVac Cl Study Group, Perret C, Kalergis AM. Le Corre N, et al. Among authors: meng x. Vaccines (Basel). 2023 Sep 26;11(10):1526. doi: 10.3390/vaccines11101526. Vaccines (Basel). 2023. PMID: 37896930 Free PMC article.
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.
Soto JA, Melo-González F, Gutierrez-Vera C, Schultz BM, Berríos-Rojas RV, Rivera-Pérez D, Piña-Iturbe A, Hoppe-Elsholz G, Duarte LF, Vázquez Y, Moreno-Tapia D, Ríos M, Palacios PA, Garcia-Betancourt R, Santibañez Á, Pacheco GA, Mendez C, Andrade CA, Silva PH, Diethelm-Varela B, Astudillo P, Calvo M, Cárdenas A, González M, Goldsack M, Gutiérrez V, Potin M, Schilling A, Tapia LI, Twele L, Villena R, Grifoni A, Sette A, Weiskopf D, Fasce RA, Fernández J, Mora J, Ramírez E, Gaete-Argel A, Acevedo ML, Valiente-Echeverría F, Soto-Rifo R, Retamal-Díaz A, Muñoz-Jofré N; PedCoronaVac03CL Study Group,; Meng X, Xin Q, Alarcón-Bustamante E, González-Aramundiz JV, Le Corre N, Álvarez-Figueroa MJ, González PA, Abarca K, Perret C, Carreño LJ, Bueno SM, Kalergis AM. Soto JA, et al. Among authors: meng x. mBio. 2022 Dec 20;13(6):e0131122. doi: 10.1128/mbio.01311-22. Epub 2022 Nov 16. mBio. 2022. PMID: 36383021 Free PMC article.
14,000 results
You have reached the last available page of results. Please see the User Guide for more information.